A head-to-head comparison of Paclical with Abraxane in women with metastatic breast cancer

Trial Profile

A head-to-head comparison of Paclical with Abraxane in women with metastatic breast cancer

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Nov 2015

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Pharmacokinetics
  • Sponsors Oasmia Pharmaceutical
  • Most Recent Events

    • 05 Nov 2015 Final results published in an Oasmia Pharmaceutical media release.
    • 05 Nov 2015 Status changed from active, no longer recruiting to completed, according to an Oasmia Pharmaceutical media release.
    • 05 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top